Jack Anders is CFO at Revolution Medicines, Inc. (RVMD). They have made 12 open-market trades across 1 company since 2020, most recently 2026-09-16.
CIK 0001800668
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 12 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RVMD | 119,216 | $21.2M |
Shares reported on the most recent Form 4, priced at the 2026-09-18 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RVMD | SELL · 10b5-1 | 2026-09-16 | 2026-09-18 | $199.24 | $808K | +6.8% | — | — |
| RVMD | SELL · 10b5-1 | 2026-06-24 | 2026-06-26 | $168.33 | $3.4M | +4.8% | +3.1% | +9.5% |
| RVMD | SELL · 10b5-1 | 2026-06-16 | 2026-06-18 | $156.12 | $425K | +15.5% | +11.1% | +20.8% |
| RVMD | SELL · 10b5-1 | 2026-03-17 | 2026-03-19 | $99.48 | $548K | -0.7% | +49.3% | +61.1% |
| RVMD | SELL · 10b5-1 | 2026-01-07 | 2026-01-09 | $98.00 | $980K | +1.7% | -17.2% | -17.6% |
| RVMD | SELL · 10b5-1 | 2025-12-16 | 2025-12-18 | $77.09 | $479K | +2.7% | +49.8% | +26.5% |
| RVMD | SELL · 10b5-1 | 2025-11-25 | 2025-11-26 | $74.00 | $401K | +0.2% | +4.0% | +35.0% |
| RVMD | SELL · 10b5-1 | 2025-11-11 | 2025-11-13 | $64.00 | $640K | +19.5% | +23.7% | +53.5% |
| RVMD | SELL · 10b5-1 | 2025-09-16 | 2025-09-18 | $45.82 | $213K | +2.6% | +18.7% | +68.6% |
| RVMD | SELL · 10b5-1 | 2025-09-02 | 2025-09-04 | $40.10 | $802K | +12.5% | +17.2% | +95.5% |
| RVMD | SELL · 10b5-1 | 2025-06-16 | 2025-06-18 | $39.83 | $173K | -7.8% | -4.2% | +11.8% |
| RVMD | SELL · 10b5-1 | 2025-03-17 | 2025-03-19 | $39.04 | $146K | -7.4% | -4.2% | +2.5% |
| RVMD | SELL · 10b5-1 | 2024-12-16 | 2024-12-18 | $45.40 | $120K | +1.0% | -7.0% | -11.9% |
| RVMD | SELL · 10b5-1 | 2024-10-11 | 2024-10-15 | $50.30 | $503K | -5.3% | +17.1% | -13.1% |
| RVMD | SELL · 10b5-1 | 2024-09-16 | 2024-09-18 | $44.19 | $198K | -0.2% | +11.0% | -0.6% |
| RVMD | SELL · 10b5-1 | 2024-06-17 | 2024-06-20 | $37.39 | $142K | -0.6% | +27.5% | +17.2% |
| RVMD | SELL · 10b5-1 | 2024-05-03 | 2024-05-03 | $40.03 | $400K | -1.5% | +0.4% | +13.1% |
| RVMD | SELL · 10b5-1 | 2024-03-18 | 2024-03-20 | $31.58 | $40K | -2.5% | +10.2% | +19.0% |
| RVMD | SELL · 10b5-1 | 2023-12-18 | 2023-12-20 | $25.90 | $46K | +6.8% | +2.7% | +17.5% |
| RVMD | SELL | 2023-09-18 | 2023-09-20 | $31.31 | $45K | -12.6% | -6.6% | -11.3% |
| RVMD | SELL · 10b5-1 | 2023-09-01 | 2023-09-06 | $35.05 | $701K | -7.1% | -24.8% | -29.4% |
| RVMD | SELL | 2023-06-20 | 2023-06-22 | $24.89 | $31K | +9.0% | +5.1% | +20.5% |
| RVMD | SELL | 2023-03-17 | 2023-03-21 | $21.78 | $14K | +1.9% | +15.0% | +20.8% |
| RVMD | SELL | 2022-12-19 | 2022-12-21 | $22.94 | $15K | -1.8% | +15.9% | -10.0% |
| RVMD | SELL | 2022-09-19 | 2022-09-21 | $19.04 | $9K | +14.3% | +8.8% | +29.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.